ReviewJournal of Cancer2023

The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review.

Antonio Pizuorno Machado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.